Literature DB >> 25866209

Peptidylprolyl Isomerase Pin1 Directly Enhances the DNA Binding Functions of Estrogen Receptor α.

Prashant Rajbhandari1, Mary Szatkowski Ozers1, Natalia M Solodin1, Christopher L Warren2, Elaine T Alarid3.   

Abstract

The transcriptional activity of estrogen receptor α (ERα), the key driver of breast cancer proliferation, is enhanced by multiple cellular interactions, including phosphorylation-dependent interaction with Pin1, a proline isomerase, which mediates cis-trans isomerization of the N-terminal Ser(P)(118)-Pro(119) in the intrinsically disordered AF1 (activation function 1) domain of ERα. Because both ERα and Pin1 have multiple cellular partners, it is unclear how Pin1 assists in the regulation of ERα transactivation mechanisms and whether the functional effects of Pin1 on ERα signaling are direct or indirect. Here, we tested the specific action of Pin1 on an essential step in ERα transactivation, binding to specific DNA sites. DNA binding analysis demonstrates that stable overexpression of Pin1 increases endogenous ERα DNA binding activity when activated by estrogen but not by tamoxifen or EGF. Increased DNA binding affinity is a direct effect of Pin1 on ERα because it is observed in solution-based assays with purified components. Further, our data indicate that isomerization is required for Pin1-modulation of ERα-DNA interactions. In an unbiased in vitro DNA binding microarray with hundreds of thousands of permutations of ERα-binding elements, Pin1 selectively enhances the binding affinity of ERα to consensus DNA elements. These studies reveal that Pin1 isomerization of phosphorylated ERα can directly regulate the function of the adjacent DNA binding domain, and this interaction is further modulated by ligand binding in the ligand-binding domain, providing evidence for Pin1-dependent allosteric regulation of ERα function.
© 2015 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  DNA-protein interaction; DNA-protein interaction, proline isomerization, SNAP (specificity and affinity for protein) microarray; estrogen receptor; intrinsically disordered protein; nuclear receptor; phosphorylation; prolyl isomerase

Mesh:

Substances:

Year:  2015        PMID: 25866209      PMCID: PMC4447953          DOI: 10.1074/jbc.M114.621698

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  87 in total

1.  Pin1 modulates RNA polymerase II activity during the transcription cycle.

Authors:  Yu-Xin Xu; James L Manley
Journal:  Genes Dev       Date:  2007-11-15       Impact factor: 11.361

2.  Proyl isomerase Pin1 facilitates ubiquitin-mediated degradation of cyclin-dependent kinase 10 to induce tamoxifen resistance in breast cancer cells.

Authors:  P Khanal; H J Yun; S C Lim; S G Ahn; H E Yoon; K W Kang; R Hong; H S Choi
Journal:  Oncogene       Date:  2011-12-12       Impact factor: 9.867

3.  Androgen receptor serine 81 mediates Pin1 interaction and activity.

Authors:  Raffaele La Montagna; Isabella Caligiuri; Pasquale Maranta; Chiara Lucchetti; Luca Esposito; Marco G Paggi; Giuseppe Toffoli; Flavio Rizzolio; Antonio Giordano
Journal:  Cell Cycle       Date:  2012-08-16       Impact factor: 4.534

4.  Pin1 regulates the dynamics of c-Myc DNA binding to facilitate target gene regulation and oncogenesis.

Authors:  Amy S Farrell; Carl Pelz; Xiaoyan Wang; Colin J Daniel; Zhiping Wang; Yulong Su; Mahnaz Janghorban; Xiaoli Zhang; Charlie Morgan; Soren Impey; Rosalie C Sears
Journal:  Mol Cell Biol       Date:  2013-05-28       Impact factor: 4.272

5.  A functional serine 118 phosphorylation site in estrogen receptor-alpha is required for down-regulation of gene expression by 17beta-estradiol and 4-hydroxytamoxifen.

Authors:  Jingwei Cheng; Chen Zhang; David J Shapiro
Journal:  Endocrinology       Date:  2007-07-05       Impact factor: 4.736

6.  Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Authors:  Caryn S Ross-Innes; Rory Stark; Andrew E Teschendorff; Kelly A Holmes; H Raza Ali; Mark J Dunning; Gordon D Brown; Ondrej Gojis; Ian O Ellis; Andrew R Green; Simak Ali; Suet-Feung Chin; Carlo Palmieri; Carlos Caldas; Jason S Carroll
Journal:  Nature       Date:  2012-01-04       Impact factor: 49.962

7.  Pin1 promotes GR transactivation by enhancing recruitment to target genes.

Authors:  Toryn M Poolman; Stuart N Farrow; Laura Matthews; Andrew S Loudon; David W Ray
Journal:  Nucleic Acids Res       Date:  2013-07-25       Impact factor: 16.971

8.  Multidomain integration in the structure of the HNF-4α nuclear receptor complex.

Authors:  Vikas Chandra; Pengxiang Huang; Nalini Potluri; Dalei Wu; Youngchang Kim; Fraydoon Rastinejad
Journal:  Nature       Date:  2013-03-13       Impact factor: 49.962

9.  The prolyl isomerase Pin1 acts synergistically with CDK2 to regulate the basal activity of estrogen receptor α in breast cancer.

Authors:  Chiara Lucchetti; Isabella Caligiuri; Giuseppe Toffoli; Antonio Giordano; Flavio Rizzolio
Journal:  PLoS One       Date:  2013-02-04       Impact factor: 3.240

10.  Phosphorylation at serines 104 and 106 by Erk1/2 MAPK is important for estrogen receptor-alpha activity.

Authors:  Ross S Thomas; Naveed Sarwar; Fladia Phoenix; R Charles Coombes; Simak Ali
Journal:  J Mol Endocrinol       Date:  2008-04       Impact factor: 5.098

View more
  11 in total

1.  Thyroid hormone receptor phosphorylation regulates acute fasting-induced suppression of the hypothalamic-pituitary-thyroid axis.

Authors:  Svetlana Minakhina; Vanessa De Oliveira; Sun Young Kim; Haiyan Zheng; Fredric E Wondisford
Journal:  Proc Natl Acad Sci U S A       Date:  2021-09-28       Impact factor: 11.205

2.  The Phosphorylated Estrogen Receptor α (ER) Cistrome Identifies a Subset of Active Enhancers Enriched for Direct ER-DNA Binding and the Transcription Factor GRHL2.

Authors:  Kyle T Helzer; Mary Szatkowski Ozers; Mark B Meyer; Nancy A Benkusky; Natalia Solodin; Rebecca M Reese; Christopher L Warren; J Wesley Pike; Elaine T Alarid
Journal:  Mol Cell Biol       Date:  2019-01-16       Impact factor: 4.272

Review 3.  The isomerase PIN1 controls numerous cancer-driving pathways and is a unique drug target.

Authors:  Xiao Zhen Zhou; Kun Ping Lu
Journal:  Nat Rev Cancer       Date:  2016-06-03       Impact factor: 60.716

Review 4.  Prolyl isomerase Pin1: a promoter of cancer and a target for therapy.

Authors:  Yang Chen; Ya-Ran Wu; Hong-Ying Yang; Xin-Zhe Li; Meng-Meng Jie; Chang-Jiang Hu; Yu-Yun Wu; Shi-Ming Yang; Ying-Bin Yang
Journal:  Cell Death Dis       Date:  2018-08-29       Impact factor: 8.469

Review 5.  Intrinsically disordered proteins play diverse roles in cell signaling.

Authors:  Sarah E Bondos; A Keith Dunker; Vladimir N Uversky
Journal:  Cell Commun Signal       Date:  2022-02-17       Impact factor: 5.712

Review 6.  Polyubiquitination inhibition of estrogen receptor alpha and its implications in breast cancer.

Authors:  Angeles C Tecalco-Cruz; Josué O Ramírez-Jarquín
Journal:  World J Clin Oncol       Date:  2018-08-13

Review 7.  Prolyl Isomerase Pin1 in Human Cancer: Function, Mechanism, and Significance.

Authors:  Wenchen Pu; Yuanyuan Zheng; Yong Peng
Journal:  Front Cell Dev Biol       Date:  2020-03-31

Review 8.  Pinning Down the Transcription: A Role for Peptidyl-Prolyl cis-trans Isomerase Pin1 in Gene Expression.

Authors:  Xiangming Hu; Lin-Feng Chen
Journal:  Front Cell Dev Biol       Date:  2020-03-20

9.  Targeting Pin1 by All-Trans Retinoic Acid (ATRA) Overcomes Tamoxifen Resistance in Breast Cancer via Multifactorial Mechanisms.

Authors:  Songyin Huang; Yang Chen; Zhi-Mei Liang; Na-Na Li; Yujie Liu; Yinghua Zhu; Dingzhun Liao; Xiao Zhen Zhou; Kun Ping Lu; Yandan Yao; Man-Li Luo
Journal:  Front Cell Dev Biol       Date:  2019-12-06

Review 10.  Targeting Pin1 for Modulation of Cell Motility and Cancer Therapy.

Authors:  Hsiang-Hao Chuang; Yen-Yi Zhen; Yu-Chen Tsai; Cheng-Hao Chuang; Ming-Shyan Huang; Michael Hsiao; Chih-Jen Yang
Journal:  Biomedicines       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.